NCT01581320View on ClinicalTrials.gov

Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Postmenopausal Women With Osteoporosis
Interventions
DRUG

Test group

Once a month, administration of DP-R206 \& placebo for 16 weeks

DRUG

Reference group

Once a month, administration of Bonviva \& placebo for 16 weeks

Trial Locations (1)

137-701

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

Sponsors

Lead Sponsor

Alvogen Korea
All Listed Sponsors
lead

Alvogen Korea

INDUSTRY